Ctional behavior of key rat liver cells within a three-dimensional perfused microarray bioreactor. Tissue Eng 8:49913. Robin P, Predine J, and Milgrom E (1978) Assay of unbound cortisol in plasma. J Clin Endocrinol Metab 46:27783. Roth RA and Ganey PE (2010) Intrinsic versus idiosyncratic drug-induced hepatotoxicity–two villains or one particular J Pharmacol Exp Ther 332:69297. Roth RA, Luyendyk JP, Maddox JF, and Ganey PE (2003) Inflammation and drug idiosyncrasy– is there a connection J Pharmacol Exp Ther 307:1. Scheving LA, Buchanan R, Krause MA, Zhang X, Stevenson MC, and Russell WE (2007) Dexamethasone modulates ErbB tyrosine kinase expression and signaling by way of a number of and redundant mechanisms in cultured rat hepatocytes. Am J Physiol Gastrointest Liver Physiol 293:G552 559. Schuetz EG and Guzelian PS (1984) Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Proof that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J Biol Chem 259:2007012. Schuetz EG, Wrighton SA, Barwick JL, and Guzelian PS (1984) Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Proof that glucocorticoids and pregnenolone 16 alphacarbonitrile regulate de novo synthesis of a prevalent type of cytochrome P-450 in cultures of adult rat hepatocytes and inside the liver in vivo. J Biol Chem 259:1999006. Sivaraman A, Leach JK, Townsend S, Iida T, Hogan BJ, Stolz DB, Fry R, Samson LD, Tannenbaum SR, and Griffith LG (2005) A microscale in vitro physiological model on the liver: predictive screens for drug metabolism and enzyme induction.4-Amino-7-bromoisoindolin-1-one site Curr Drug Metab six: 56991.9-Chloroacridine site Sleep D, Cameron J, and Evans LR (2013) Albumin as a versatile platform for drug half-life extension.PMID:23715856 Biochim Biophys Acta 1830:5526534. Strober W (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol three (Appendix):3B. Sunman JA, Hawke RL, LeCluyse EL, and Kashuba AD (2004) Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes. Drug Metab Dispos 32:35963. Tayman C, Rayyan M, and Allegaert K (2011) Neonatal pharmacology: in depth interindividual variability despite limited size. J Pediatr Pharmacol Ther 16:17084. Thoma CR, Zimmermann M, Agarkova I, Kelm JM, and Krek W (2014) 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69-70: 291.Hence, particularly if interactions with nonparenchymal cells are involved, the miniaturized bioreactor could be a valuable model technique to enhance predictivity in pharmacological and toxicological studies on a subchronic timescale. Moreover, the culture method facilitates histologic analyses of pharmacology-related structural traits of human liver tissue.Acknowledgments The authors thank Agilent Technologies for access for the triple quadrupole mass spectrometer. Authorship Contributions Participated in investigation design: Sarkar, Rivera-Burgos, Huge, Hughes, Ravindra, Ebrahimkhani, Wishnok, Griffith, Tannenbaum. Carried out experiments: Sarkar, Rivera-Burgos, Substantial, Ravindra, Dyer. Performed information evaluation: Sarkar, Rivera-Burgos, Significant, Ravindra, Wishnok, Tannenbaum. Wrote or contributed to the writing from the manuscript: Sarkar, Rivera-Burgos, Huge, Hughes, Ravindra, Griffith, Wishnok, Tannenbaum.
www.nature.com/scientificreportsOPENOncogenic miR-9 is actually a target of erlotinib in NSCLCsXi Chen1,*, Lingjun Zhu2,*, Zhuo Ma1, Geng Sun1, Xuan Luo1, Min Li1, Sulan Zhai1, Ping Li1 Xuerong WangEGFR-targeted cancer therap.
